Variation in human genes encoding adhesion and proinflammatory molecules are associated with severe malaria in the Vietnamese

Genes and Immunity

Volumn 13, Issue 6, 2012, Pages 503-508

  Dunstan, S J ^a,b   Rockett, K A ^c   Quyen, N T N ^a   Teo, Y Y ^d   Thai, C Q ^e   Hang, N T ^a   Jeffreys, A ^c   Clark, T G ^f   Small, K S ^g   Simmons, C P ^a,b   Day, N ^h   O'Riordan, S E ^a   Kwiatkowski, D P ^c,i   Farrar, J ^a,b   Phu, N H ^a,e   Hien, T T ^a,e  

^a OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^e UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^f LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^g KING'S COLLEGE LONDON   (United Kingdom)

^h MAHIDOL UNIVERSITY   (Thailand)

ⁱ WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

genetic association; ICAM1; IL17RC; severe malaria; SNP; TNF

Indexed keywords

ADULT; ALLELE; ARTICLE; DEATH; DISEASE SEVERITY; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOTE; HUMAN; ICAM1 GENE; IL13 GENE; IL17RC GENE; LTA GENE; MAJOR CLINICAL STUDY; MALARIA; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TNF GENE; VIET NAM;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CELL ADHESION MOLECULES; COHORT STUDIES; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; INFLAMMATION MEDIATORS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-13; INTERLEUKIN-1ALPHA; MALARIA, FALCIPARUM; MALE; PARASITEMIA; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, INTERLEUKIN; TUMOR NECROSIS FACTOR-ALPHA; VIETNAM; YOUNG ADULT;

EID: 84865640798     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2012.25     Document Type: Article

References (40)

1. World Health Organisation WH. World Malaria Report 2009. WHO: Geneva, 2009.
2. National Institute of Malariology Preventation and Epidemiology. Annual Report of Malaria and Parasite Prevention in 2010. National Institute of Malariology Pre-ventation and Epidemiology: Hanoi, Vietnam, 2010.
3. Barat LM. Four malaria success stories: how malaria burden was successfully reduced in Brazil, Eritrea, India, and Vietnam. Am J Trop Med Hyg 2006; 74: 12-16.
4. Hung le Q, Vries PJ, Giao PT, Nam NV, Binh TQ, Chong MT et al. Control of malaria: a successful experience from Viet Nam. Bull World Health Organ 2002; 80: 660-666.
5. Erhart A, Thang ND, Xa NX, Thieu NQ, Hung LX, Hung NQ et al. Accuracy of the health information system on malaria surveillance in Vietnam. Trans R Soc Trop Med Hyg 2007; 101: 216-225.
6. Trung HD, Van Bortel W, Sochantha T, Keokenchanh K, Quang NT, Cong LD et al. Malaria transmission and major malaria vectors in different geographical areas of Southeast Asia. Trop Med Int Health 2004; 9: 230-237.
7. Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J et al. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 2009; 361: 455-467.
8. Bejon P, Lusingu J, Olotu A, Leach A, Lievens M, Vekemans J et al. Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age. N Engl J Med 2008; 359: 2521-2532.
9. Abdulla S, Oberholzer R, Juma O, Kubhoja S, Machera F, Membi C et al. Safety and immunogenicity of RTS,S/AS02D malaria vaccine in infants. N Engl J Med 2008; 359: 2533-2544.
10. Webster DP, Dunachie S, Vuola JM, Berthoud T, Keating S, Laidlaw SM et al. Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara. Proc Natl Acad Sci USA 2005; 102: 4836-4841.
11. Dunachie SJ, Walther M, Epstein JE, Keating S, Berthoud T, Andrews L et al. A DNA prime-modified vaccinia virus ankara boost vaccine encoding thrombospondin-related adhesion protein but not circumsporozoite protein partially protects healthy malaria-naive adults against Plasmodium falciparum sporozoite challenge. Infect Immun 2006; 74: 5933-5942.
12. Goodman AL, Draper SJ. Blood-stage malaria vaccines\recent progress and future challenges. Ann Trop Med Parasitol 2010; 104: 189-211.
13. MalariaGEN Network. A global network for investigating the genomic epidemiology of malaria. Nature 2008; 456: 732-737.
14. Taylor TE, Fu WJ, Carr RA, Whitten RO, Mueller JS, Fosiko NG et al. Differentiating the pathologies of cerebral malaria by postmortem parasite counts. Nat Med 2004; 10: 143-145.
15. Fernandez-Reyes D, Craig AG, Kyes SA, Peshu N, Snow RW, Berendt AR et al. A high frequency African coding polymorphism in the N-terminal domain of ICAM-1 predisposing to cerebral malaria in Kenya. Hum Mol Genet 1997; 6: 1357-1360.
16. Kun JF, Klabunde J, Lell B, Luckner D, Alpers M, May J et al. Association of the ICAM-1Kilifi mutation with protection against severe malaria in Lambarene, Gabon. Am J Trop Med Hyg 1999; 61: 776-779.
17. Bellamy R, Kwiatkowski D, Hill AV. Absence of an association between intercellular adhesion molecule 1, complement receptor 1 and interleukin 1 receptor antagonist gene polymorphisms and severe malaria in a West African population. Trans R Soc Trop Med Hyg 1998; 92: 312-316.
18. Ndiaye R, Sakuntabhai A, Casademont I, Rogier C, Tall A, Trape JF et al. Genetic study of ICAM1 in clinical malaria in Senegal. Tissue Antigens 2005; 65: 474-480.
19. Ohashi J, Naka I, Patarapotikul J, Hananantachai H, Looareesuwan S, Tokunaga K. Absence of association between the allele coding methionine at position 29 in the N-terminal domain of ICAM-1 (ICAM-1(Kilifi)) and severe malaria in the northwest of Thailand. Jpn J Infect Dis 2001; 54: 114-116.
20. Fry AE, Auburn S, Diakite M, Green A, Richardson A, Wilson J et al. Variation in the ICAM1 gene is not associated with severe malaria phenotypes. Genes Immun 2008; 9: 462-469.
21. Amodu OK, Gbadegesin RA, Ralph SA, Adeyemo AA, Brenchley PE, Ayoola OO et al. Plasmodium falciparum malaria in south-west Nigerian children: is the polymorphism of ICAM-1 and E-selectin genes contributing to the clinical severity of malaria? Acta Trop 2005; 95: 248-255.
22. Sinha S, Qidwai T, Kanchan K, Anand P, Jha GN, Pati SS et al. Variations in host genes encoding adhesion molecules and susceptibility to falciparum malaria in India. Malar J 2008; 7: 250.
23. McGuire W, Hill AV, Allsopp CE, Greenwood BM, Kwiatkowski D. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 1994; 371: 508-510.
24. Clark TG, Diakite M, Auburn S, Campino S, Fry AE, Green A et al. Tumor necrosis factor and lymphotoxin-alpha polymorphisms and severe malaria in African populations. J Infect Dis 2009; 199: 569-575.
25. Ackerman HC, Ribas G, Jallow M, Mott R, Neville M, Sisay-Joof F et al. Complex haplotypic structure of the central MHC region flanking TNF in a West African population. Genes Immun 2003; 4: 476-486.
26. Newton JL, Harney SM, Timms AE, Sims AM, Rockett K, Darke C et al. Dissection of class III major histocompatibility complex haplotypes associated with rheumatoid arthritis. Arthritis Rheum 2004; 50: 2122-2129.
27. Mfuna EL, Cormier C, Bosse Y, Filali-Mouhim A, Desrosiers M. Association of IL1A, IL1B, and TNF gene polymorphisms with chronic rhinosinusitis with and without nasal polyposis: a replication study. Arch Otolaryngol Head Neck Surg 136: 187-192.
28. Karjalainen J, Hulkkonen J, Pessi T, Huhtala H, Nieminen MM, Aromaa A et al. The IL1A genotype associates with atopy in nonasthmatic adults. J Allergy Clin Immunol 2002; 110: 429-434.
29. Sims AM, Timms AE, Bruges-Armas J, Burgos-Vargas R, Chou CT, Doan T et al. Prospective meta-analysis of interleukin 1 gene complex polymorphisms confirms associations with ankylosing spondylitis. Ann Rheum Dis 2008; 67: 1305-1309.
30. Han W, Kang SY, Kang D, Park SK, Lee JY, Kim H et al. Multiplex genotyping of 1107 SNPs from 232 candidate genes identified an association between IL1A polymorphism and breast cancer risk. Oncol Rep 23: 763-769.
31. Walley AJ, Aucan C, Kwiatkowski D, Hill AV. Interleukin-1 gene cluster polymorphisms and susceptibility to clinical malaria in a Gambian case-control study. Eur J Hum Genet 2004; 12: 132-138.
32. Gyan B, Goka B, Cvetkovic JT, Perlmann H, Lefvert AK, Akanmori B et al. Polymorphisms in interleukin-1beta and interleukin-1 receptor antagonist genes and malaria in Ghanaian children. Scand J Immunol 2002; 56: 619-622.
33. Ho AW, Gaffen SL. IL-17RC: a partner in IL-17 signaling and beyond. Semin Immunopathol 2010; 32: 33-42.
34. Toy D, Kugler D, Wolfson M, Vanden Bos T, Gurgel J, Derry J et al. Cutting edge: interleukin 17 signals through a heteromeric receptor complex. J Immunol 2006; 177: 36-39.
35. van de Veerdonk FL, Gresnigt MS, Kullberg BJ, van der Meer JW, Joosten LA, Netea MG. Th17 responses and host defense against microorganisms: an overview. BMB Rep 2009; 42: 776-787.
36. Eid NA, Hussein AA, Elzein AM, Mohamed HS, Rockett KA, Kwiatkowski DP et al. Candidate malaria susceptibility/protective SNPs in hospital and population-based studies: the effect of sub-structuring. Malar J 9: 119.
37. Fumagalli M, Pozzoli U, Cagliani R, Comi GP, Riva S, Clerici M et al. Parasites represent a major selective force for interleukin genes and shape the genetic predisposition to autoimmune conditions. J Exp Med 2009; 206: 1395-1408.
38. Jallow M, Teo YY, Small KS, Rockett KA, Deloukas P, Clark TG et al. Genome-wide and fine-resolution association analysis of malaria in West Africa. Nat Genet 2009; 41: 657-665.
39. Phu NH, Tuan PQ, Day N, Mai NT, Chau TT, Chuong LV et al. Randomized controlled trial of artesunate or artemether in Vietnamese adults with severe falci-parum malaria. Malar J 9: 97.
40. Tran TH, Day NP, Nguyen HP, Nguyen TH, Tran TH, Pham PL et al. A controlled trial of artemether or quinine in Vietnamese adults with severe falciparum malaria. N Engl J Med 1996; 335: 76-83.